Results 151 to 160 of about 3,009,219 (314)

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

open access: yesMolecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain   +10 more
wiley   +1 more source

Management of Common Medical Conditions in End-Stage Kidney Disease by the General Practitioner

open access: yesTurkish Journal of Nephrology, 2023
Emran El-Alali, Emad Al-Jaber
doaj   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Simulation of the performance of WALES based on an end-to-end model

open access: yes, 2004
WALES (Water Vapour Lidar Experiment in Space) is one of the experiments considered by ESA for selection as Earth Explorer Core mission in the frame of the Earth Observation Envelope Programme.
Kiemle, Christoph   +15 more
core  

End conditions for interpolatory cubic splines with unequally spaced knots

open access: yes, 1980
A class of end conditions is derived for cubic spline interpolation at unequally spaced knots. These conditions are in terms of function values at the knots and lead to 0 (h4) convergence uniformly on the interval of ...
Papamichael, N., Behforooz, G.H.
core   +1 more source

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

open access: yesMolecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak   +10 more
wiley   +1 more source

Skin levels of advanced glycation end products in correlation with periodontal conditions – a pilot study

open access: yesBMC Oral Health
Background Although associations between periodontitis and metabolic diseases are established, published data about the correlation of advanced glycation end products (AGEs) and periodontal inflammation are scarce.
M. Cyris   +8 more
doaj   +1 more source

Front-end Conditions for Product-service System Design

open access: yes, 2016
This research shows the preliminary results of ongoing research in the understanding of front-end conditions that lever the organization's general disposition toward creating new product-service systems.
Dewit, Ivo
core   +1 more source

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Optimizing the conditions for the DNA two end immobilization

open access: yes, 2022
We are studying the conditions required to optimize the two end DNA immobilization on the PEG functionalized ...
Gautam, Dinesh
core  

Home - About - Disclaimer - Privacy